Eagle Genomics raised €3.1M in a funding round in Jan 2019. The company is based in Cambridge, UK. Investors in the round: ETF Partners. Data as of 25 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
